These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

726 related items for PubMed ID: 18653492

  • 1. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function.
    Staals LM, Snoeck MM, Driessen JJ, Flockton EA, Heeringa M, Hunter JM.
    Br J Anaesth; 2008 Oct; 101(4):492-7. PubMed ID: 18653492
    [Abstract] [Full Text] [Related]

  • 2. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA, Mastronardi P, Hunter JM, Gomar C, Mirakhur RK, Aguilera L, Giunta FG, Meistelman C, Prins ME.
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [Abstract] [Full Text] [Related]

  • 3. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK, Gordon M, Demeyer I, Sparr HJ, Ingimarsson J, Klarin B, van Duijnhoven W, Heeringa M.
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
    de Souza CM, Tardelli MA, Tedesco H, Garcia NN, Caparros MP, Alvarez-Gomez JA, de Oliveira Junior IS.
    Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
    [Abstract] [Full Text] [Related]

  • 5. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M.
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [Abstract] [Full Text] [Related]

  • 6. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK, Caldwell JE, Brull SJ, Soto RG.
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block.
    Shields M, Giovannelli M, Mirakhur RK, Moppett I, Adams J, Hermens Y.
    Br J Anaesth; 2006 Jan; 96(1):36-43. PubMed ID: 16357116
    [Abstract] [Full Text] [Related]

  • 9. Train-of-four ratio recovery often precedes twitch recovery when neuromuscular block is reversed by sugammadex.
    Staals LM, Driessen JJ, Van Egmond J, De Boer HD, Klimek M, Flockton EA, Snoeck MM.
    Acta Anaesthesiol Scand; 2011 Jul; 55(6):700-7. PubMed ID: 21574968
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
    Czarnetzki C, Tassonyi E, Lysakowski C, Elia N, Tramèr MR.
    Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
    [Abstract] [Full Text] [Related]

  • 12. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study.
    Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Ostergaard D, Prins ME, Viby-Mogensen J.
    Anesthesiology; 2006 Apr; 104(4):667-74. PubMed ID: 16571960
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of sugammadex in patients with a history of pulmonary disease.
    Amao R, Zornow MH, Cowan RM, Cheng DC, Morte JB, Allard MW.
    J Clin Anesth; 2012 Jun; 24(4):289-97. PubMed ID: 22608583
    [Abstract] [Full Text] [Related]

  • 17. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
    Rahe-Meyer N, Berger C, Wittmann M, Solomon C, Abels EA, Rietbergen H, Reuter DA.
    Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients.
    Suzuki T, Kitajima O, Ueda K, Kondo Y, Kato J, Ogawa S.
    Br J Anaesth; 2011 Jun; 106(6):823-6. PubMed ID: 21531745
    [Abstract] [Full Text] [Related]

  • 20. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
    Pühringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS.
    Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.